Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Prevalence and Management of Symptoms Associated With Statin Therapy in Community Practice: Insights From the PALM (Patient and Provider Assessment of Lipid Management) Registry.

Literature DB >> 29545393

Prevalence and Management of Symptoms Associated With Statin Therapy in Community Practice: Insights From the PALM (Patient and Provider Assessment of Lipid Management) Registry.

Ann Marie Navar¹, Eric D Peterson², Shuang Li², Jennifer G Robinson², Veronique L Roger², Anne C Goldberg², Salim Virani², Peter W F Wilson², Michael G Nanna², L Veronica Lee², Joseph Elassal², Tracy Y Wang².

Abstract

Entities: Chemical Disease Gene Species

Keywords: Hydroxymethylglutaryl-CoA reductase inhibitors; cardiovascular disease; drug-related side effects and adverse reactions; nocebo effect

Mesh：

Substances：

Year: 2018 PMID： 29545393 PMCID： PMC5858190 DOI： 10.1161/CIRCOUTCOMES.117.004249

Source DB: PubMed Journal: Circ Cardiovasc Qual Outcomes ISSN： 1941-7713

× No keyword cloud information.

10 in total

1. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors: Neil J Stone; Jennifer G Robinson; Alice H Lichtenstein; C Noel Bairey Merz; Conrad B Blum; Robert H Eckel; Anne C Goldberg; David Gordon; Daniel Levy; Donald M Lloyd-Jones; Patrick McBride; J Sanford Schwartz; Susan T Shero; Sidney C Smith; Karol Watson; Peter W F Wilson; Karen M Eddleman; Nicole M Jarrett; Ken LaBresh; Lev Nevo; Janusz Wnek; Jeffrey L Anderson; Jonathan L Halperin; Nancy M Albert; Biykem Bozkurt; Ralph G Brindis; Lesley H Curtis; David DeMets; Judith S Hochman; Richard J Kovacs; E Magnus Ohman; Susan J Pressler; Frank W Sellke; Win-Kuang Shen; Sidney C Smith; Gordon F Tomaselli
Journal: Circulation Date: 2013-11-12 Impact factor: 29.690

Review 2. The nocebo effect in the context of statin intolerance.

Authors: Jonathan A Tobert; Connie B Newman
Journal: J Clin Lipidol Date: 2016-05-13 Impact factor: 4.766

3. Predictors of statin adherence, switching, and discontinuation in the USAGE survey: understanding the use of statins in America and gaps in patient education.

Authors: Melissa Y Wei; Matthew K Ito; Jerome D Cohen; Eliot A Brinton; Terry A Jacobson
Journal: J Clin Lipidol Date: 2013-03-13 Impact factor: 4.766

4. Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial.

Authors: Patrick M Moriarty; Paul D Thompson; Christopher P Cannon; John R Guyton; Jean Bergeron; Franklin J Zieve; Eric Bruckert; Terry A Jacobson; Stephen L Kopecky; Marie T Baccara-Dinet; Yunling Du; Robert Pordy; Daniel A Gipe
Journal: J Clin Lipidol Date: 2015-08-29 Impact factor: 4.766

5. Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients--the PRIMO study.

Authors: Eric Bruckert; Gilles Hayem; Sylvie Dejager; Caroline Yau; Bernard Bégaud
Journal: Cardiovasc Drugs Ther Date: 2005-12 Impact factor: 3.727

Review 6. Interpretation of the evidence for the efficacy and safety of statin therapy.

Authors: Rory Collins; Christina Reith; Jonathan Emberson; Jane Armitage; Colin Baigent; Lisa Blackwell; Roger Blumenthal; John Danesh; George Davey Smith; David DeMets; Stephen Evans; Malcolm Law; Stephen MacMahon; Seth Martin; Bruce Neal; Neil Poulter; David Preiss; Paul Ridker; Ian Roberts; Anthony Rodgers; Peter Sandercock; Kenneth Schulz; Peter Sever; John Simes; Liam Smeeth; Nicholas Wald; Salim Yusuf; Richard Peto
Journal: Lancet Date: 2016-09-08 Impact factor: 79.321

7. Prevalence of musculoskeletal pain and statin use.

Authors: Catherine Buettner; Roger B Davis; Suzanne G Leveille; Murray A Mittleman; Kenneth J Mukamal
Journal: J Gen Intern Med Date: 2008-05-01 Impact factor: 5.128

8. Design and rationale for the Patient and Provider Assessment of Lipid Management (PALM) registry.

Authors: Ann Marie Navar; Tracy Y Wang; Anne C Goldberg; Jennifer G Robinson; Veronique L Roger; Peter F Wilson; Salim S Virani; Joesph Elassal; L Veronica Lee; Laura E Webb; Eric Peterson
Journal: Am Heart J Date: 2015-08-07 Impact factor: 4.749

9. Discontinuation and restarting in patients on statin treatment: prospective open cohort study using a primary care database.

Authors: Yana Vinogradova; Carol Coupland; Peter Brindle; Julia Hippisley-Cox
Journal: BMJ Date: 2016-06-28

Review 10. Non-cardiovascular effects associated with statins.

Authors: Chintan S Desai; Seth S Martin; Roger S Blumenthal
Journal: BMJ Date: 2014-07-17

10 in total

7 in total

Review 1. Bempedoic Acid: The New Kid on the Block for the Treatment of Dyslipidemia and LDL Cholesterol: A Narrative Review.

Authors: Uazman Alam; Dalal Y Al-Bazz; Handrean Soran
Journal: Diabetes Ther Date: 2021-05-26 Impact factor: 2.945

2. Patient-Reported Reasons for Declining or Discontinuing Statin Therapy: Insights From the PALM Registry.

Authors: Corey K Bradley; Tracy Y Wang; Shuang Li; Jennifer G Robinson; Veronique L Roger; Anne C Goldberg; Salim S Virani; Michael J Louie; L Veronica Lee; Eric D Peterson; Ann Marie Navar
Journal: J Am Heart Assoc Date: 2019-04-02 Impact factor: 5.501

3. Intensity of Lipid Lowering With Statin Therapy in Patients With Cerebrovascular Disease Versus Coronary Artery Disease: Insights from the PALM Registry.

Authors: Ying Xian; Ann Marie Navar; Shuang Li; Zhuokai Li; Jennifer Robinson; Salim S Virani; Michael J Louie; Andrew Koren; Anne Goldberg; Veronique L Roger; Peter W F Wilson; Eric D Peterson; Tracy Y Wang
Journal: J Am Heart Assoc Date: 2019-09-26 Impact factor: 5.501